Gordon Research Conference on Autophagy series
Gordon Research Conference on Autophagy series
批准号:
8062113
负责人:
VOJO P DERETIC
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2013-03-31
关键词:
AddressAffectAgingAging-Related ProcessAreaAutoimmunityAutophagocytosisAutophagosomeBiological ProcessCancer Immunology ScienceCategoriesCell DeathCell SurvivalChronicCommunitiesDevelopmentDiabetes MellitusDiseaseGoalsGrowthHealthHumanHypersensitivityImmune System DiseasesImmunityInfectionInflammationInflammatoryInternationalItalyKnowledgeLeadMalignant NeoplasmsMetabolic DiseasesMuscular AtrophyMyopathyNatural ImmunityNerve DegenerationNeurologyNormal CellParticipantPathologic ProcessesPathway interactionsPharmaceutical PreparationsPhysiciansPhysiological ProcessesRegulationRequest for ProposalsResearchResearch PersonnelRoleScientistSeriesSignal TransductionSiteSumTranslationsWorkadaptive immunitybasegraduate studenthuman diseaseimmune functionmeetingsnext generationnormal agingnovelnovel strategiespostersprogramspublic health relevancesymposium
中文摘要
描述(由申请人提供):本提案要求对将于2010年4月25日至30日在意大利Il Ciocco以及2012年和2014年在待定地点举行的自噬戈登研究会议(GRC)系列(3次会议)提供部分支持。自噬是影响正常衰老和广泛的主要人类疾病类别的基本细胞稳态机制。这些疾病作为独立的实体是重要的,同时与衰老有关:癌症、神经变性、炎症、肌肉和免疫疾病以及代谢紊乱。这个GRC系列的广泛和长期目标是促进一种综合方法,以定义自噬在人类衰老和疾病的生理和病理过程中迅速扩大的作用。自噬GRC系列将有助于阐明自噬途径以及自噬如何与正常细胞存活和死亡途径或其异常有关。这些会议的具体目标将是召集40名代表自噬研究关键领域的演讲者和讨论领导者,共有120多名与会者参加三次(2010年,2012年和2014年)为期五天的会议。2010年的该项目将包括一场主题演讲和八场会议,广泛讨论自噬调节、自噬信号传导、自噬机制、自噬体起源、选择性自噬以及自噬在代谢疾病和癌症中的作用等当前问题、先天性和适应性免疫、衰老和神经病学。此外,两次晚间海报会议将使所有与会者都能对这些主题作出贡献。在2012年和2014年,类似的项目将涵盖自噬的基本方面,并继续强调其在衰老,神经变性,肌病,代谢疾病,癌症和免疫学(包括感染,炎症和自身免疫)中的作用。这一应用的重要性在于,自噬GRCs已成为年度系列会议的核心,这些会议对国际自噬学者群体的研究产生了重大影响,指导和推动。这些会议汇集了处于自噬领域最前沿的研究人员,并为初级科学家和研究生提供机会,以海报形式展示他们的工作,并与该领域的领导者交流思想,从而培养下一代自噬研究领导者。本申请的健康相关性在于自噬直接影响广泛的人类健康和疾病状态,包括衰老、神经变性、癌症、代谢紊乱、肌变性、免疫功能和炎性疾病。GRC会议对自噬的研究将导致对正常衰老过程的更深入了解;有助于开发治疗神经变性,肌肉萎缩,癌症,代谢疾病,感染,慢性炎症和免疫疾病的新方法。
公共卫生相关性:自噬是一个新认识的基本生物学过程,影响人类健康的几乎所有方面,包括衰老,神经退行性疾病,癌症,感染和免疫,炎症和过敏,代谢疾病和糖尿病,肌肉萎缩等。自噬GRCs在发现自噬与人类健康之间以前未知的联系以及将目前获得的知识转化为新药和新疗法方面发挥了重要作用。总而言之,自噬GRCs代表了一个关键的场所,推动了这一领域前所未有的360度增长,这一领域已经成为一个基于自噬的看似不同的人类疾病的连续体,为广泛的疾病提供了以前未曾预料到但现实的治疗方法。该领域的许多领导者都是执业医生,进一步证明了自噬与人类健康,衰老和疾病状态的直接关系。
英文摘要
DESCRIPTION (provided by applicant): This proposal requests partial support for the Gordon Research Conference (GRC) series on Autophagy (3 conferences) to be held in Il Ciocco, Italy April 25-30, 2010, and in 2012 and 2014 at yet to be determined sites. Autophagy is a fundamental cellular homeostatic mechanism affecting normal aging and a wide spectrum of major human disease categories. These diseases are significant as standalone entities while being associated with aging: cancer, neurodegeneration, inflammation, muscle and immune diseases, and metabolic disorders. The broad and long term goal of this GRC series is to promote an integrated approach in defining the rapidly expanding role of autophagy in physiological and pathological processes that underlie human aging and diseases. The Autophagy GRC series will facilitate elucidation of the autophagy pathway and how autophagy pertains to normal cell survival and death pathways or their anomalies. The specific aims of these meetings will be to convene 40 speakers and discussion leaders that represent critical areas of autophagy research with a total of over 120 participants for three (2010, 2012, and 2014) five day conferences. The program in 2010 will feature a keynote address and eight sessions that broadly address current issues in regulation of autophagy, autophagy signaling, autophagy machinery, origin of the autophagosome, selective autophagy, and roles of autophagy in metabolic diseases and cancer, innate and adaptive immunity, aging and neurology. In addition, two evening poster sessions will permit all participants to contribute to these topics. In 2012 and 2014, similar programs will cover fundamental aspects of autophagy and place continued and increased emphasis on its role in aging, neurodegeneration, myopathies, metabolic disease, cancer, and immunology including infection, inflammation and autoimmunity. The significance of this application is that the Autophagy GRCs have become the centerpiece of the yearly series of conferences that critically influence, direct and propel research in the international community of autophagy scholars. These conferences bring together investigators who are at the forefront of the autophagy field, and provide opportunities for junior scientists and graduate students to present their work in poster format and exchange ideas with leaders in the field thus nurturing the next generation of autophagy research leaders. The health relatedness of this application is that autophagy directly impacts a wide spectrum of human health and disease states including aging, neurodegeneration, cancer, metabolic disorders, myodegeneration, immune functions and inflammatory diseases. The research spurred by GRC meetings on autophagy will lead to a greater understanding of normal aging processes; help to develop new approaches in treatments of neurodegeneration, muscle atrophy, cancer, metabolic diseases, infection, chronic inflammation and immune disorders.
PUBLIC HEALTH RELEVANCE: Autophagy is a newly appreciated fundamental biological process that impacts nearly all facets of human health, including aging, neurodegeneration, cancer, infection and immunity, inflammation and allergy, metabolic diseases and diabetes, muscle atrophy, etc. The growing realization of the broad impact of autophagy on human health is in part the result of vigorous scientific exchange facilitated by previous Gordon Research Conferences (GRC) on Autophagy. The Autophagy GRCs have been instrumental in the discovery of previously unknown connections between autophagy and human health and the translation of presently acquired knowledge into new drugs and novel treatments. In sum, the Autophagy GRCs represent a key venue fueling the unprecedented 360o growth of this field within what has emerged as an autophagy-based continuum of seemingly diverse human diseases, offering development of previously unanticipated but realistic treatments for a broad spectrum of disorders. Many of the leaders in this field are practicing physicians, further attesting to the direct relationship of autophagy to human health, aging, and disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
-
批准号:9207186
-
项目类别:
-
资助金额:$245.71万
-
财政年份:2017
-
负责人:VOJO P DERETIC
-
依托单位:
AIM Administrative Core
-
批准号:10249117
-
项目类别:
-
资助金额:$70.63万
-
财政年份:2017
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
-
批准号:10249116
-
项目类别:
-
资助金额:$218.04万
-
财政年份:2017
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy-based HDT for tuberculosis
-
批准号:9150518
-
项目类别:
-
资助金额:$56.14万
-
财政年份:2015
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:9232996
-
项目类别:
-
资助金额:$65.82万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:10570827
-
项目类别:
-
资助金额:$73.7万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:9769998
-
项目类别:
-
资助金额:$74.45万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:10092897
-
项目类别:
-
资助金额:$74.45万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:8707081
-
项目类别:
-
资助金额:$65.6万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:9025642
-
项目类别:
-
资助金额:$65.75万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy Against Tuberculosis and HIV
-
批准号:10357752
-
项目类别:
-
资助金额:$73.7万
-
财政年份:2014
-
负责人:VOJO P DERETIC
-
依托单位:
Gordon Research Conference on Autophagy series
-
批准号:7904694
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2010
-
负责人:VOJO P DERETIC
-
依托单位:
Gordon Research Conference on Autophagy series
-
批准号:8239523
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2010
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy and Crohn's Disease
-
批准号:7834330
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy and Crohn's Disease
-
批准号:7936210
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7329824
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7192792
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7992442
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7534373
-
项目类别:
-
资助金额:$36.54万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
Autophagy in Tuberculosis
-
批准号:7736807
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2006
-
负责人:VOJO P DERETIC
-
依托单位:
海外基金